Document is current
Any future updates will be listed below
-
Authors
Wang, Xiaoxue
Long, Ting
Shen, Lening
Hu, Yichen
Zou, Yachao
Wang, Zixuan
Yang, Kaiqiang
Dai, Fang
Song, Li
-
Funding
Funding for this research was provided by:
the National Natural Science Foundation of China (no. 82460196)
the Key R&D Program of Jiangxi Province, China (no. 20252BCG330024)
the Double Thousand Talents Project of Jiangxi Province (no. jxsq2023201045)
the High-level and High-skilled Leading Talent Training Project of Jiangxi Province (no. G/Y3034)
- License Information
-
More Information
Article History
Received: 30 August 2025
Accepted: 29 January 2026
First Online: 5 February 2026
Declarations
:
: The study protocol involving human participants was conducted in accordance with the principles of the Declaration of Helsinki. It was reviewed and approved by the Ethics Committee of the Second Affiliated Hospital of Nanchang University (Reference No. O-MedResEthRev No. (17); MR-36-24-041017). The trial was registered with the Chinese Clinical Trial Registry (Registration No. ChiCTR2500108690). All the individuals provided written informed consent prior to enrollment.
: Not applicable.
: The authors declare no competing interests.
